About this source
- Kind
- Research
- Design
- Narrative review
- Primary or secondary
- secondary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Narrative review, ahead of print. Only the abstract was read (full text is subscription-only). Used here for the fragment-versus-full-length distinction, not as new evidence.
Cited in
TB-500 is a seven-residue fragment, not the full peptide
Thymosin beta-4 · Research finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.